Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery (PROTISLEEVE)

May 2, 2024 updated by: University Hospital, Montpellier

Randomized Controlled Trial Prospective Single-center Open Evaluating the Efficacy of Supplementation (Adapted to the Post-operative Period) Current Protein After Bariatric Surgery Like Sleeve Gastrectomy

The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy.

Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy.

Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain.

There is still no study evaluating the protein supplementation adapted patients after sleeve gastrectomy on maintaining lean body mass.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • UHMontpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • surgical management of sleeve gastrectomy kind

Exclusion Criteria:

  • food allergies
  • Weight> 135 kg (maximum weight supported by the DXA)
  • orthopedic prosthesis (hip, knee ...) that would make it impossible to interpret the measurement of DXA
  • History of bariatric surgery: adjustable gastric banding, vertical banded gastrectomy ...

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: usual dietary management
Control group: usual dietary management Following the intervention, the stomach of patients underwent many changes
Experimental: care of with usual dietary protein supplementation
Intervention group: Usual dietary management with protein supplementation (30g) in addition to the usual inputs
Protein supplementation : Protein intake of 30 grams of protein in addition to the usual inputs (to the recommended amounts of 60 to 120 g per day), upon the resumption of oral intake until the fifth week after sleeve gastrectomy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in lean mass (kg) will be assessed at the level of whole-body dual-energy X-ray absorptiometry (DXA)
Time Frame: up to 1 month
up to 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
food diary
Time Frame: 5 weeks after the hospital discharge
The actual protein intake will be assessed using a food diary over 5 weeks completed by the patient
5 weeks after the hospital discharge
change rate IGF1, IGFBP3
Time Frame: up to 1 month
change rate IGF1, IGFBP3 between hospitalization and 1 month of hospital discharge
up to 1 month
the quality of life
Time Frame: up to 1 month
The evolution of the quality of life will be assessed through a specific scale, Baros score.
up to 1 month
the quality of life
Time Frame: up to 5 years
The evolution of the quality of life will be assessed through a specific scale, Baros score.
up to 5 years
change rate IGF1, IGFBP3
Time Frame: up to 5 years
change rate IGF1, IGFBP3 between hospitalization and 5 years follow up
up to 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David NOCCA, University Hospital, Montpellier

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 19, 2016

Primary Completion (Actual)

October 30, 2023

Study Completion (Actual)

October 30, 2023

Study Registration Dates

First Submitted

March 14, 2016

First Submitted That Met QC Criteria

March 16, 2016

First Posted (Estimated)

March 17, 2016

Study Record Updates

Last Update Posted (Actual)

May 3, 2024

Last Update Submitted That Met QC Criteria

May 2, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL15_0173
  • UF 9590 (Other Identifier: Montpellier University Hospital)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on protein supplementation

3
Subscribe